# A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis

> **NCT02985593** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 155 (actual)

## Conditions studied

- Healthy Men and Subjects With Ulcerative Colitis

## Interventions

- **DRUG:** KHK4083
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02985593
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12
- **Primary completion:** 2017-12-26
- **Final completion:** 2017-12-26
- **Target enrollment:** 155 (ACTUAL)
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985593, "A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02985593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*